Back to search

National and Kapodistrian University of Athens

Μελέτη επιγενετικών μηχανισμών στη χρόνια λεμφοκυτταρική λευχαιμία

Abstract

dc:description

Aberrant DNA methylation is implicated in the pathogenesis of chronic lymphocytic leukemia (CLL), however its contribution to disease progression has not been conclusively defined. In study I, we investigated the role of DNA methylation changes overtime in a group of CLL patients homogeneously treated with fludarabine, cyclophosphamide and rituximab (FCR). We determined methylation profiles in 34 CLL patients before treatment and at relapse. Overtime analysis highlighted the active role of DNA methylation changes in CLL evolution, particularly in regards to response to chemoimmunotherapy, involving several transcription factors and pathways. The DNA methylation changes showed correlation with the time to first treatment and the time to relapse, hence offering strong evidence regarding the active role of epigenetics in disease evolution, including the response to treatment. Moreover, our findings raise the possibility of using the DNA methylation levels of specific CpGs as prognostic biomarkers. CLL cases show different cytogenetic alterations with clinical value, but it is unclear whether distinct CLL cytogenetic subgroups have different epigenetic landscapes. In study II, we analyzed whether DNA methylation profiles can be linked to the pathophysiology of particular cytogenetic subgroups. We investigated 245 CLL cases carrying del(11q), del(13q) or trisomy 12. The trisomy 12 cases showed distinct DNA methylation patterns, further underscoring their unique biological background. We found low correlation between DNA methylation and gene expression, in line with recent reports. Moreover, integration analysis demonstrated the complexity of the epigenetic markers by linking the DNA methylation data with acetylation and chromatin accessibility data. Finally, del(11q) cases showed a high epigenetic burden (i.e. number of DMCpGs per case compared to memory B cells), which represents a potential predictive biomarker for CLL. Apart from the genetic alterations, CLL cases exhibit distinct immunogetic characteristics such as the antigen receptor stereotypy. The cases belonging to these stereotyped subsets show homogeneous clinicobiologically characteristics, even at epigenetic level. In study III, we analyzed the DNA methylation profiles of patients belonging to stereotyped subset #6 and #8 as well as non-subset U-CLL patients and we found distinct epigenetic signatures. The epigenetic signature showed a low correlation with gene expression in the line of previous reports. The TP63 gene, which is a member of TP53 family, showed the highest differences on DNA methylation levels between the two subsets. Moreover, TP63 was hypomethylated and overexpressed in subset #8, which exhibits the highest risk of Richter syndrome among all CLL subgroups. Altogether, this thesis confirms the significance of DNA methylation in CLL, provides insight into the mechanism of the progression and relapse and further unravels the DNA methylation landscape in cytogenetic subgroups and stereotyped subsets of CLL.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsagiopoulou, Maria
  • Τσαγιοπούλου, Μαρία

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48076

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsagiopoulou, Maria; Τσαγιοπούλου, Μαρία. Μελέτη επιγενετικών μηχανισμών στη χρόνια λεμφοκυτταρική λευχαιμία. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/48076